Literature DB >> 18393389

Caspase activation is associated with spontaneous recovery from acute liver failure.

Xandra Volkmann1, Matthias Anstaett, Johannes Hadem, Penelope Stiefel, Matthias J Bahr, Frank Lehner, Michael P Manns, Klaus Schulze-Osthoff, Heike Bantel.   

Abstract

UNLABELLED: Acute liver failure (ALF) has various causes and is characterized by rapid hepatocyte dysfunction with development of encephalopathy in the absence of preexisting liver disease. Whereas most patients require liver transplantation to prevent the high mortality, some patients recover spontaneously and show complete liver regeneration. Because of the low incidence of ALF, however, the molecular mechanisms of liver dysfunction and regeneration are largely unknown. In this study, we investigated the role of apoptosis and caspases in 70 ALF patients using novel biomarkers that allow the detection of caspase activation in serum samples. Compared with healthy individuals, activation of caspases was strongly enhanced in ALF patients. Interestingly, patients with spontaneous recovery from ALF revealed a significantly higher activation of caspases than patients that required transplantation or died, although in the latter patients extensive DNA fragmentation and signs of nonapoptotic cell death were observed. In the spontaneous survivors, increased caspase activation was accompanied by elevated levels of tumor necrosis factor alpha (TNF-alpha) and interleukin-6 (IL-6), important cytokines involved in liver regeneration.
CONCLUSION: Our data suggest that caspase activation and apoptosis are involved in ALF of patients with spontaneous recovery, whereas caspase-independent cell death might be more relevant in irreversible forms of liver failure. These findings might be important for therapeutic options of ALF but also suggest that measurement of caspase activation might be of prognostic value to predict the outcome of acute liver failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18393389     DOI: 10.1002/hep.22237

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

1.  The mechanism underlying acetaminophen-induced hepatotoxicity in humans and mice involves mitochondrial damage and nuclear DNA fragmentation.

Authors:  Mitchell R McGill; Matthew R Sharpe; C David Williams; Mohammad Taha; Steven C Curry; Hartmut Jaeschke
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

2.  RETRACTED: Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.

Authors:  Daniel J Antoine; Rosalind E Jenkins; James W Dear; Dominic P Williams; Mitchell R McGill; Matthew R Sharpe; Darren G Craig; Kenneth J Simpson; Hartmut Jaeschke; B Kevin Park
Journal:  J Hepatol       Date:  2012-01-17       Impact factor: 25.083

Review 3.  [Diagnosis and therapies for acute liver failure: scientific developments].

Authors:  M Ott; T Cantz; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

4.  Prognostic value of M30/M65 for outcome of hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Su-Jun Zheng; Shuang Liu; Mei Liu; Malcolm A McCrae; Jun-Feng Li; Yuan-Ping Han; Chun-Hui Xu; Feng Ren; Yu Chen; Zhong-Ping Duan
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 5.  Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.

Authors:  Nam-On Ku; Pavel Strnad; Heike Bantel; M Bishr Omary
Journal:  Hepatology       Date:  2016-04-04       Impact factor: 17.425

6.  Incorporating dynamics for predicting poor outcome in acute liver failure patients.

Authors:  Robert Afm Chamuleau; Kama A Wlodzimirow; Ameen Abu-Hanna
Journal:  World J Gastrointest Surg       Date:  2012-12-27

7.  Development of an accurate index for predicting outcomes of patients with acute liver failure.

Authors:  Anna Rutherford; Lindsay Y King; Linda S Hynan; Chetan Vedvyas; Wenyu Lin; William M Lee; Raymond T Chung
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

Review 8.  Apoptosis and necroptosis in the liver: a matter of life and death.

Authors:  Robert F Schwabe; Tom Luedde
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-12       Impact factor: 46.802

Review 9.  Liver transplantation in acute liver failure: A challenging scenario.

Authors:  Manuel Mendizabal; Marcelo Oscar Silva
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

10.  Cell death serum biomarkers are early predictors for survival in severe septic patients with hepatic dysfunction.

Authors:  Stefan Hofer; Thorsten Brenner; Christian Bopp; Jochen Steppan; Christoph Lichtenstern; Jürgen Weitz; Thomas Bruckner; Eike Martin; Ursula Hoffmann; Markus A Weigand
Journal:  Crit Care       Date:  2009-06-18       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.